Ameritas Investment Partners
IMRX icon

Ameritas Investment Partners’s Immuneering IMRX Stock Holding History

Ameritas Investment Partners’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.3K Buy
+4,866
New +$24.6K ﹤0.01% 2655
2024
Q2 		– Sell
-1,675
Closed -$4.84K – 3179
2024
Q1 		$4.84K Hold
1,675
– – ﹤0.01% 2954
2023
Q4 		$12.3K Hold
1,675
– – ﹤0.01% 2777
2023
Q3 		$12.9K Hold
1,675
– – ﹤0.01% 2723
2023
Q2 		$17K Buy
+1,675
New +$16.1K ﹤0.01% 2643
2022
Q2 		– Sell
-634
Closed -$4K – 3146
2022
Q1 		$4K Hold
634
– – ﹤0.01% 2995
2021
Q4 		$10K Hold
634
– – ﹤0.01% 2893
2021
Q3 		$17K Buy
+634
New +$17K ﹤0.01% 2773

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Ameritas Investment Partners's IMRX Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Immuneering (IMRX) in Q2 2026: 4,866 shares worth $24.3K. The stake represents ﹤0.01% of the portfolio and ranks #2655 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in IMRX as recently as Q1 2024.

Ameritas Investment Partners first reported a position in IMRX in Q3 2021 and has held it in 8 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Ameritas Investment Partners held 4,866 shares of Immuneering worth $24.3K as of Q2 2026.
  • Immuneering was a new Ameritas Investment Partners position in Q2 2026.
  • Immuneering made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2655 holding.
  • Ameritas Investment Partners first reported a position in Immuneering in Q3 2021 and has held it in 8 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.